Literature DB >> 3994564

gamma-Aminobutyric acid in CSF of children with febrile seizures.

M Knight, J Ebert, R A Parish, H Berry, M H Fogelson.   

Abstract

Previous studies have suggested that levels of cerebrospinal fluid (CSF) gamma-aminobutyric acid (GABA) may be decreased in children with febrile seizures. We used gas chromatography and mass spectrometry to measure CSF GABA levels in 14 children with febrile seizures. The results were compared with the GABA levels in six children with first-time afebrile seizures, three with recurrent febrile seizures, and 13 controls (febrile children undergoing lumbar puncture to rule out meningitis). Children with central nervous system infections or known neurologic disease were excluded. The CSF GABA levels in children with febrile seizures were not significantly different from those in controls and children with afebrile or recurrent febrile seizures. In the control group, CSF GABA levels correlated with increasing age. There was no correlation with severity of febrile response in any group. The results indicated that the CSF GABA level may not be abnormal in patients with first-time febrile convulsions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994564     DOI: 10.1001/archneur.1985.04060050076011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.

Authors:  A Pitkänen; R Matilainen; T Halonen; R Kutvonen; P Hartikainen; P Riekkinen
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

2.  Cerebrospinal fluid zinc concentrations in febrile convulsions.

Authors:  B Z Garty; R Olomucki; T Lerman-Sagie; M Nitzan
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

3.  Anticonvulsive effect of paeoniflorin on experimental febrile seizures in immature rats: possible application for febrile seizures in children.

Authors:  Hitomi Hino; Hisaaki Takahashi; Yuka Suzuki; Junya Tanaka; Eiichi Ishii; Mitsumasa Fukuda
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.